TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,559,000 | -31.2% | 47,300 | -75.5% | 0.00% | -100.0% |
| Q1 2022 | $5,176,000 | -36.0% | 192,773 | +13.7% | 0.00% | 0.0% |
| Q4 2021 | $8,086,000 | -20.7% | 169,541 | +10.4% | 0.00% | 0.0% |
| Q3 2021 | $10,198,000 | -1.8% | 153,520 | +15.3% | 0.00% | 0.0% |
| Q2 2021 | $10,384,000 | +66.0% | 133,114 | +101.3% | 0.00% | 0.0% |
| Q1 2021 | $6,256,000 | -9.9% | 66,138 | +16.0% | 0.00% | 0.0% |
| Q4 2020 | $6,946,000 | +35.7% | 57,016 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $5,117,000 | +43.3% | 58,584 | +6.0% | 0.00% | 0.0% |
| Q2 2020 | $3,571,000 | +639.3% | 55,276 | +411.6% | 0.00% | – |
| Q1 2020 | $483,000 | -24.8% | 10,805 | +4.8% | 0.00% | – |
| Q4 2019 | $642,000 | +89.4% | 10,312 | +14.3% | 0.00% | – |
| Q3 2019 | $339,000 | +208.2% | 9,025 | +233.0% | 0.00% | – |
| Q2 2019 | $110,000 | – | 2,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |